Pfizer (PFE) Inventory (2009 - 2026)
Pfizer (PFE) posted quarterly Inventory of $10.7 billion for Q1 2026, down 1.7% year-over-year from $10.9 billion in Q1 2025, and little changed quarter-over-quarter from $10.7 billion in Q4 2025.
Pfizer (PFE) Inventory (2009 - 2026) Analysis & Trends
Pfizer (PFE) has reported Inventory for 18 consecutive years, with $10.7 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory fell 1.7% year-over-year to $10.7 billion; the TTM figure through Mar 2026 stood at $10.7 billion (down 1.7% YoY), while the FY2025 annual figure was $10.7 billion, down 1.82% from the prior year.
- Inventory steadied at $10.7 billion in Q1 2026 per PFE's latest filing, from $10.7 billion in the prior quarter.
- Across five years, Inventory topped out at $11.7 billion in Q3 2024 and bottomed at $9.0 billion in Q4 2022.
- Historically, Inventory has averaged $10.6 billion across 5 years, with a median of $10.7 billion in 2026.
- Annual changes were most pronounced in 2022 — Inventory climbed 17.5% — and 2023, when it declined 4.39%.
- Pfizer's Inventory stood at $9.0 billion in 2022, then advanced by 13.45% to $10.2 billion in 2023, then grew by 6.5% to $10.9 billion in 2024, then decreased by 1.82% to $10.7 billion in 2025, then climbed by 0.12% to $10.7 billion in 2026.
- Business Quant data shows PFE's Inventory at $10.7 billion in Q1 2026, $10.7 billion in Q4 2025, and $11.5 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 15.14 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 5.13 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 6.21 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 6.22 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 6.93 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 6.22 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 1.95 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 9.95 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 8.43 Bn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 12.93 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 9.95 Bn |
| Mar 29, 2026 | 10.67 Bn |
| Dec 31, 2025 | 10.65 Bn |
| Sep 28, 2025 | 11.47 Bn |
| Jun 29, 2025 | 11.67 Bn |
| Mar 30, 2025 | 10.85 Bn |
| Dec 31, 2024 | 10.85 Bn |
| Sep 29, 2024 | 11.72 Bn |
| Jun 30, 2024 | 11.45 Bn |
| Mar 31, 2024 | 10.89 Bn |
| Dec 31, 2023 | 10.19 Bn |
| Jul 2, 2023 | 10.31 Bn |
| Apr 2, 2023 | 9.54 Bn |
| Dec 31, 2022 | 8.98 Bn |
| Jul 3, 2022 | 10.45 Bn |
| Apr 3, 2022 | 9.98 Bn |
| Dec 31, 2021 | 9.06 Bn |
| Oct 3, 2021 | 8.64 Bn |
| Jul 4, 2021 | 8.95 Bn |
| Apr 4, 2021 | 8.49 Bn |